ADAM Metallopeptidase Domain 9 (ADAM9) (C-Term) Peptide
| Name | ADAM Metallopeptidase Domain 9 (ADAM9) |
| Synonyms | adam9-A, MDC9, ADAM-9, Adam9, zgc:101824, ADAM9, LOC100101585, MCMP, Mltng, KIAA0021, AU020942, mKIAA0021 |
| Binding Site |
C-Term |
![]() |
3 references available |
| Certificates | ISO 9001:2008 |
| Catalog no. | ABIN697051 |
| Quantity | 0.1 mg |
| Price | 49.50 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 2 to 3 Business Days |
Additional Information
| Immunogen | Synthetic peptide |
| Characteristics | Blocking peptide for ADAM9 (C-term) antibody ABIN652337 |
| Specificity | The synthetic peptide sequence used to generate the antibody AP7437b was selected from the C-term region of human ADAM9. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
| Comments |
Background: ADAM9 is a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. This protein interacts with SH3 domain-containing proteins, binds mitotic arrest deficient 2 beta protein, and is also involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. |
Application Details
| Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles |
| Restrictions | For Research Use only |
Publications
| Product |
Weskamp, Krätzschmar, Reid et al.: "MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains." in: The Journal of cell biology, Vol. 132, Issue 4, pp. 717-26, 1996 (PubMed).
McKie, Edwards, Dallas et al.: "Expression of members of a novel membrane linked metalloproteinase family (ADAM) in human articular chondrocytes." in: Biochemical and biophysical research communications, Vol. 230, Issue 2, pp. 335-9, 1997 (PubMed). Hotoda, Koike, Sasagawa et al.: "A secreted form of human ADAM9 has an alpha-secretase activity for APP." in: Biochemical and biophysical research communications, Vol. 293, Issue 2, pp. 800-5, 2002 (PubMed). |




